BRPI0516457A - uso de um composto, e, composição farmacêutica para a administração pulmonar do composto ou de um sal farmaceuticamente aceitável, de uma pró-droga ou de um solvato do mesmo - Google Patents
uso de um composto, e, composição farmacêutica para a administração pulmonar do composto ou de um sal farmaceuticamente aceitável, de uma pró-droga ou de um solvato do mesmoInfo
- Publication number
- BRPI0516457A BRPI0516457A BRPI0516457-5A BRPI0516457A BRPI0516457A BR PI0516457 A BRPI0516457 A BR PI0516457A BR PI0516457 A BRPI0516457 A BR PI0516457A BR PI0516457 A BRPI0516457 A BR PI0516457A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pulmonary administration
- solvate
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000002685 pulmonary effect Effects 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000012453 solvate Substances 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 208000007536 Thrombosis Diseases 0.000 abstract 2
- 229940123900 Direct thrombin inhibitor Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000003868 thrombin inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
USO DE UM COMPOSTO, E, COMPOSIçãO FARMACêUTICA PARA A ADMINISTRAçãO PULMONAR DO COMPOSTO OU DE UM SAL FARMACEUTICAMENTE ACEITáVEL, DE UMA PRó-DROGA OU DE UM SOLVATO DO MESMO. A invenção refere-se ao uso de um conjugado de oligossacarídeo a um inibidor direto de trombina para a fabricação de um medicamento para a administração pulmonar do dito composto para a prevenção ou para o tratamento de trombose ou de distúrbios relacionados à trombose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104897 | 2004-10-06 | ||
| PCT/EP2005/054973 WO2006037771A1 (en) | 2004-10-06 | 2005-10-03 | Pulmonary administration of an antithrombotic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0516457A true BRPI0516457A (pt) | 2008-09-02 |
Family
ID=34929670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0516457-5A BRPI0516457A (pt) | 2004-10-06 | 2005-10-03 | uso de um composto, e, composição farmacêutica para a administração pulmonar do composto ou de um sal farmaceuticamente aceitável, de uma pró-droga ou de um solvato do mesmo |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20090227528A1 (pt) |
| EP (1) | EP1799229B1 (pt) |
| JP (1) | JP2008515849A (pt) |
| CN (1) | CN101035545A (pt) |
| AR (1) | AR051319A1 (pt) |
| AT (1) | ATE418990T1 (pt) |
| AU (1) | AU2005291307B2 (pt) |
| BR (1) | BRPI0516457A (pt) |
| CA (1) | CA2581051A1 (pt) |
| DE (1) | DE602005012130D1 (pt) |
| DK (1) | DK1799229T3 (pt) |
| ES (1) | ES2318551T3 (pt) |
| IL (1) | IL182008A (pt) |
| MX (1) | MX2007003873A (pt) |
| PE (1) | PE20060968A1 (pt) |
| PL (1) | PL1799229T3 (pt) |
| TW (1) | TW200621794A (pt) |
| WO (1) | WO2006037771A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103145774A (zh) * | 2013-03-21 | 2013-06-12 | 苏州鸿洋医药科技有限公司 | 一种抗凝戊糖及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
| WO1999065934A1 (en) * | 1998-06-17 | 1999-12-23 | Akzo Nobel N.V. | Antithrombotic compounds |
| US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
| TWI289566B (en) * | 1999-12-07 | 2007-11-11 | N.V.Organon | Antithrombotic compound |
| AU2440802A (en) * | 2000-10-18 | 2002-04-29 | Massachusetts Inst Technology | Methods and products related to pulmonary delivery of polysaccharides |
| WO2003035030A1 (en) * | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
-
2005
- 2005-09-19 TW TW094132329A patent/TW200621794A/zh unknown
- 2005-10-03 DK DK05796923T patent/DK1799229T3/da active
- 2005-10-03 ES ES05796923T patent/ES2318551T3/es not_active Expired - Lifetime
- 2005-10-03 WO PCT/EP2005/054973 patent/WO2006037771A1/en not_active Ceased
- 2005-10-03 CN CNA2005800339541A patent/CN101035545A/zh active Pending
- 2005-10-03 CA CA002581051A patent/CA2581051A1/en not_active Abandoned
- 2005-10-03 PL PL05796923T patent/PL1799229T3/pl unknown
- 2005-10-03 MX MX2007003873A patent/MX2007003873A/es active IP Right Grant
- 2005-10-03 JP JP2007535150A patent/JP2008515849A/ja active Pending
- 2005-10-03 AU AU2005291307A patent/AU2005291307B2/en not_active Ceased
- 2005-10-03 DE DE602005012130T patent/DE602005012130D1/de not_active Expired - Lifetime
- 2005-10-03 EP EP05796923A patent/EP1799229B1/en not_active Expired - Lifetime
- 2005-10-03 AT AT05796923T patent/ATE418990T1/de not_active IP Right Cessation
- 2005-10-03 BR BRPI0516457-5A patent/BRPI0516457A/pt not_active IP Right Cessation
- 2005-10-03 US US11/664,803 patent/US20090227528A1/en not_active Abandoned
- 2005-10-04 AR ARP050104187A patent/AR051319A1/es unknown
- 2005-10-04 PE PE2005001170A patent/PE20060968A1/es not_active Application Discontinuation
-
2007
- 2007-03-19 IL IL182008A patent/IL182008A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101035545A (zh) | 2007-09-12 |
| US20090227528A1 (en) | 2009-09-10 |
| WO2006037771A1 (en) | 2006-04-13 |
| AU2005291307B2 (en) | 2011-02-10 |
| HK1102692A1 (en) | 2007-11-30 |
| MX2007003873A (es) | 2007-05-18 |
| ES2318551T3 (es) | 2009-05-01 |
| PE20060968A1 (es) | 2006-10-11 |
| JP2008515849A (ja) | 2008-05-15 |
| EP1799229B1 (en) | 2008-12-31 |
| CA2581051A1 (en) | 2006-04-13 |
| AU2005291307A1 (en) | 2006-04-13 |
| DE602005012130D1 (de) | 2009-02-12 |
| TW200621794A (en) | 2006-07-01 |
| DK1799229T3 (da) | 2009-04-27 |
| AR051319A1 (es) | 2007-01-03 |
| IL182008A0 (en) | 2007-07-24 |
| IL182008A (en) | 2010-12-30 |
| ATE418990T1 (de) | 2009-01-15 |
| EP1799229A1 (en) | 2007-06-27 |
| PL1799229T3 (pl) | 2009-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0513843A (pt) | composto ou um sal ou solvato ou uma pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, forma de dosagem, uso de um composto, e, sal de cloridrato | |
| HN2005000255A (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis | |
| CY1116688T1 (el) | Τροποποιητες φαρμακοκινητικων ιδιοτητων θεραπευτικων ειδων | |
| TW200736223A (en) | N-(pyridin-2-yl)-sulfonamide derivatives | |
| BRPI0509863A (pt) | liberação de fármaco para fundo de olho | |
| BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
| WO2005097125A3 (en) | Methods and compositions for the treatment, prevention or management of diysfunctional sleep and dysfunctional sleep associated with disease | |
| WO2008020040A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of fibrosis | |
| UY26926A1 (es) | Derivados de la quinolina y quinazolina | |
| UY28958A1 (es) | Nuevos derivados de piridazin-3(2h)-ona | |
| UY27462A1 (es) | Derivados de quinolina | |
| NO20076595L (no) | Behandling av leversykdommer hvor jern spiller en rolle i patogenesen | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| WO2007128086A3 (en) | Novel viral replication inhibitor | |
| BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
| GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| BRPI0415053B8 (pt) | inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| AR064543A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
| WO2008005352A3 (en) | Solid dose formulations of a thrombin receptor antagonist | |
| WO2008004100A9 (en) | Therapeutic compounds | |
| BRPI0516810A (pt) | uso de conjugados de lipìdios no tratamento de doenças | |
| BRPI0516457A (pt) | uso de um composto, e, composição farmacêutica para a administração pulmonar do composto ou de um sal farmaceuticamente aceitável, de uma pró-droga ou de um solvato do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |